In the SURMOUNT-1 trial published in the New England Journal of Medicine, participants taking Zepbound achieved remarkable average weight reductions: 15% (34 lbs) at the 5mg dose, 19.5% (43 lbs) at 10mg, and 20.9% (approximately 48 lbs) at the highest 15mg dose over 72 weeks
As shown in the carousel above, Fractyl uses endoscopic ultrasound a routine outpatient technique to deliver their AAV vectors directly into pancreatic tissue
Understanding how these treatments work and differ can offer great insight to our prospective patients.

1 Introduction Acute Mountain Sickness (AMS) is a common and potentially debilitating condition that affects individuals ascending to altitudes above 2,500 m above sea level ( 2 ), a condition known as hypobaric hypoxia ( Notably, studies have established that exposure to hypobaric hypoxia promotes a redox imbalance, leading to an exacerbated increase in reactive oxygen species (ROS) along with deterioration of endogenous antioxidant defenses ( 2 O 2 ) in exhaled breath condensate (EBC), both at rest and during exercise at altitude, correlating with decreased arterial oxygen saturation and AMS symptom severity ( Based on these findings, various studies have proposed antioxidant use as a preventive therapeutic strategy, given that the only pharmacological treatment currently employed to mitigate AMS is acetazolamide, along with anti-inflammatory agents such as dexamethasone and ibuprofen

A medication like Ozempic can be a helpful tool in combating weight loss, but it isnt the end-all solution